Day: April 26, 2022

Aker Horizons, through its portfolio company Aker Clean Hydrogen, and Statkraft have signed collaboration agreements to jointly explore opportunities for green hydrogen and ammonia production in India and Brazil, targeting local steel and fertilizer industries. The collaboration brings together Aker Clean Hydrogen, a global integrated hydrogen, ammonia and methanol producer building on Aker’s 180 years of industrial heritage, and Statkraft, a leading developer and generator of renewable energy with a substantial experience and presence in India and Brazil. “With considerable renewable energy production and market activities in India and Brazil, Statkraft is well positioned to capture green hydrogen opportunities in these two huge and important energy markets. Developing such opportunities helps us grow our business and reduces greenhouse...

2022 First QuarterPress release – Paris, April 26th, 2022 Q1 Sales up +24% driven by LFL, thanks to strong local demandAmericas and EMEA outstanding momentumContinuation of full price strategyDigital penetration of 25%Q1 Sales at €283.0m, up +23.7% on an organic1 basis vs. 2021, fully driven by a LFL2 growth thanks to strong local demand Outstanding momentum in the Americas and EMEA3 (resp.+44.5% and +72.9% on an organic basis vs. 2021) Despite a good start to the quarter in APAC4 (successful Chinese New Year), recent Covid restrictions had a significant impact on sales, first in Hong-Kong and later in Mainland China Progressive improvement in France over the quarter, outperforming the market Successful execution of the One journey strategic plan, including:Continuation of the full price strategy (discount rate down by -6.1 pp...

MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it entered into a securities purchase agreement with certain institutional and accredited investors for aggregate gross proceeds of approximately $19.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company. In connection with the offering, the Company will issue 4,862,845 units and pre-funded units at a purchase price of $4.01 per unit, priced at-the-market under Nasdaq rules. Each unit and pre-funded unit consist of 1 share of common stock or common stock equivalent, and 2 non-tradable warrants, each warrant...

ZURICH Glattbrugg, 26 April 2021 – gategroup Holding AG (“gategroup”, the “Company” and together with its subsidiaries, the “Group”), published today its full-year results and Annual Report for the financial year ending 31 December 2021. Revenues were increased by 35% to CHF 2.097 billion in 2021 (vs. CHF 1.552 billion in 2020). EBITDA was positive, with a profit of CHF 60.5 million in 2021 (vs. a loss of CHF -256.7 million in 2020). Cash and cash equivalents were at CHF 246.6 million as per December 31, 2021 compared to CHF 302.9 million at the end of 2020. “With a solid increase in business volume in airline catering towards the end of 2021 and the continuing growth of our food services business,” says Christoph Schmitz, CEO of gategroup, “the group is well positioned to benefit from the continuing recovery of the aviation industry in...

SOUTH SAN FRANCISCO, Calif., April 25, 2022 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock at a price to the public of $15.00 per share. The Company has granted the underwriters a 30-day option to purchase up to 2,000,000 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. All shares in the offering are to be issued and sold by Nkarta. The offering is expected to close on or about April 28, 2022, subject to customary closing conditions. Gross proceeds to Nkarta from this offering are approximately $200 million, before deducting underwriting discounts and commissions and...

Enabling real-time data streams for data analytics, starting with Synopsys’ Silicon Lifecycle Management platform Highlights:New ACS Nexus enables real-time data streaming from distributed test floors across the semiconductor supply chain for the analytics solutions of customers and third-parties  Strategic collaboration between Synopsys and Advantest enables real-time data analytics in Synopsys’ SiliconDash. Advantest’s ACS open solution ecosystem is expanded through Synopsys’ Silicon Lifecycle Management platform.             TOKYO, April 25, 2022 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) and Synopsys (Nasdaq: SNPS), a leading provider of EDA software and data analytics solutions for the semiconductor ecosystem, have enabled real-time data analytics in Synopsys’ SiliconDash...